Business Context and Reporting Period
CareDx, Inc. filed a Form 8-K on November 13, 2018, reporting the entry into a material definitive agreement for an underwritten public offering of common stock. The company is an emerging growth company incorporated in Delaware.
Key Financial Metrics and Transaction Details
- Shares Offered: 2,000,000 shares of common stock.
- Public Offering Price: $24.50 per share.
- Underwriting Price: $23.03 per share.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 300,000 additional shares at the public offering price.
- Expected Net Proceeds: Approximately $45.9 million (excluding proceeds from the over-allotment option), after deducting underwriting discounts, commissions, and estimated offering expenses.
- Expected Closing Date: On or about November 16, 2018.
Material Changes and Agreements
The primary material change is the execution of an Underwriting Agreement with Jefferies LLC and Piper Jaffray & Co. as joint book-running managers. This agreement facilitates the capital raise described above. Additionally, the company's directors and executive officers entered into "lock-up" agreements prohibiting the sale or transfer of company securities until February 12, 2019, without prior written consent.
Guidance, Risks, and Contingencies
The filing contains forward-looking statements regarding the anticipated closing of the offering and expected proceeds. Management cautioned that these statements are subject to risks and uncertainties, including the ability to satisfy closing conditions on a timely basis and general market conditions. The company does not intend to update these forward-looking statements except as required by law. The filing does not provide specific operational guidance or revenue forecasts beyond the transaction details.
Investor Verification Checklist
- Verify the actual closing date and final number of shares sold, including any exercise of the 300,000 share over-allotment option.
- Confirm the final net proceeds received after all transaction expenses are settled.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific covenants and indemnification terms.
- Monitor compliance with the lock-up agreement expiration on February 12, 2019, for potential insider selling pressure.